CS Diagnostics Statistics
Total Valuation
CS Diagnostics has a market cap or net worth of 46.25 million. The enterprise value is 46.25 million.
| Market Cap | 46.25M |
| Enterprise Value | 46.25M |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CS Diagnostics has 249.99 million shares outstanding. The number of shares has increased by 33.49% in one year.
| Current Share Class | 249.99M |
| Shares Outstanding | 249.99M |
| Shares Change (YoY) | +33.49% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.00% |
| Owned by Institutions (%) | n/a |
| Float | 46.06M |
Valuation Ratios
The trailing PE ratio is 2,384.68.
| PE Ratio | 2,384.68 |
| Forward PE | n/a |
| PS Ratio | 468.43 |
| PB Ratio | 0.09 |
| P/TBV Ratio | 1,690.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2,384.79 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.27
| Current Ratio | 19.27 |
| Quick Ratio | 19.27 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 0.00% |
| Weighted Average Cost of Capital (WACC) | -127.32% |
| Revenue Per Employee | 98,730 |
| Profits Per Employee | 19,394 |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.09% in the last 52 weeks. The beta is -23.92, so CS Diagnostics's price volatility has been lower than the market average.
| Beta (5Y) | -23.92 |
| 52-Week Price Change | -65.09% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 43.42 |
| Average Volume (20 Days) | 41,313 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.17 |
Income Statement
In the last 12 months, CS Diagnostics had revenue of 98,730 and earned 19,394 in profits. Earnings per share was 0.00.
| Revenue | 98,730 |
| Gross Profit | 98,730 |
| Operating Income | 19,394 |
| Pretax Income | 19,394 |
| Net Income | 19,394 |
| EBITDA | n/a |
| EBIT | 19,394 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 13 in cash and n/a in debt, giving a net cash position of 13 or 0.00 per share.
| Cash & Cash Equivalents | 13 |
| Total Debt | n/a |
| Net Cash | 13 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 499.43M |
| Book Value Per Share | 3.64 |
| Working Capital | 29,404 |
Cash Flow
| Operating Cash Flow | -21,375 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 19.64% and 19.64%.
| Gross Margin | 100.00% |
| Operating Margin | 19.64% |
| Pretax Margin | 19.64% |
| Profit Margin | 19.64% |
| EBITDA Margin | n/a |
| EBIT Margin | 19.64% |
| FCF Margin | n/a |
Dividends & Yields
CS Diagnostics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.49% |
| Shareholder Yield | -33.49% |
| Earnings Yield | 0.04% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on August 3, 2023. It was a reverse split with a ratio of 0.002.
| Last Split Date | Aug 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.002 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |